Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
MAP Pharmaceuticals (MAPP)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: MAPP
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Biotech Discounts Galore
The Burrill Report
•
Aug 09
•
1 Comment
Closing Update for Thursday July 16
Midnight Trader
•
Jul 09
•
Comment!
FDA, Clinical Trial Updates: MAP Pharma, Cytokinetics, Hemispherx Post Big Gains
Mike Havrilla
•
May 27
•
1 Comment
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Mark Cifra
•
Apr 02
•
5 Comments
Chink in the Biotechnology Armor
Michael Becker
•
Mar 01
•
4 Comments
Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008
Market Folly
•
Dec 30
•
Comment!
More articles on MAPP »
Instablogs
FDA, Clinical Trial Updates: MAPP, CYTK, and HEB Post Big Gains
Tue May 26, 2009
•
Mike Havrilla
•
Comment!
Write a post on MAPP
|
More Instablogs on MAPP »
Sentiment
What advice would you give to
MAPP?
123 characters left
What's your view of MAPP?
Make sure you include MAPP
140 characters left
|
Settings